Related Experiment Video
Updated: Jul 30, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Advice-giving in community pharmacy: variations between pharmacies in different locations
Health & Place
|February 12, 2000
Summary
Community pharmacies offer vital primary health care, but service quality varies by location. An ethnographic study reveals local environments significantly impact pharmacy services, potentially creating disparities in underserved areas.
Area of Science:
- Pharmacy Practice
- Primary Health Care
- Health Services Research
Background:
- Community pharmacies are increasingly recognized as essential primary health care resources.
- Limited research exists on variations in pharmacy services across different localities.
- Understanding these variations is crucial for equitable healthcare delivery.
Purpose of the Study:
- To investigate differences in the nature and quality of advice and services provided by community pharmacies in diverse locations.
- To explore how the local environment influences pharmacy service provision.
- To examine potential health disparities related to pharmacy services in urban versus rural areas.
Main Methods:
- An ethnographic study was conducted to observe and understand pharmacy operations.
- Qualitative data were collected and analyzed to identify patterns and differences.
- The study focused on pharmacies in disparate urban and rural localities.
Main Results:
- Significant variations in the type and quality of advice and services were observed between pharmacies in different localities.
- The pharmacy's environment and organizational factors were found to influence service delivery.
- Evidence suggests a potential inverse care law, with poorer services in disadvantaged urban areas compared to rural settings.
Conclusions:
- Local environmental factors significantly shape community pharmacy services.
- Disparities in pharmacy services may exist based on geographic and socioeconomic factors.
- Further research is needed to address potential inequities in primary health care provision by community pharmacies.
Related Concept Videos
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...